In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. Specialty pharmacy continues to be dynamic, demanding and disruptive.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. 2023 was a momentous year for community pharmacy in Canada.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. The date January 1 can have varying meanings for people.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review.
In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year.
Healthcare Distribution Alliance (HDA) president and CEO Chip Davis released the following statement regarding the Food and Drug Administration’s (FDA) decision to authorize the Florida Agency for Health Care Administration’s drug importation program under section 804 of the Federal Food, Drug, and
CVS Health announced several leadership updates, effective immediately: • Senior vice president of Corporate Finance and interim CFO, Tom Cowhey, has been formally appointed the company’s next CFO.
CVS Caremark, a CVS Health company, announced this week the continuation of its efforts to expand adoption of biosimilars. Effective April 1, 2024, Humira will be removed from our major national commercial template formularies and Humira biosimilars will be covered.
PRINCETON, N.J. – Dr. Reddy’s Laboratories announced that it has acquired MenoLabs business, a leading women’s health and dietary supplement branded portfolio from Amyris, Inc. (“Amyris”) in Amyris’ Chapter 11 sales process. Dr.
Justin Heiser has officially taken over as the new president and CEO at Thrifty White Pharmacy. Heiser’s appointment was first announced last May, following the news that Robert (Bob) Narveson president and CEO of Thrifty White Pharmacy for almost 33 years, was stepping down from his role.
Today, VSP Vision announced that AARP members will be eligible for exclusive individual vision and eyewear insurance plans from VSP Vision.
Pfizer said this week it plans to lay off 285 workers at its Pearl River campus in New York as the company struggles financially, in good part, due to declining demand for its COVID-19 vaccines and products, state records show. The Pfizer job cuts will begin Feb. 12 and continue through late
The American Pharmacists Association (APhA) announced today that it has entered into a contracted project agreement with CDC’s Applied Research and Evaluation Branch in the Division for Heart Disease and Stroke Prevention to accelerate the implementation of pharmacy-based strategies to advance healt
